Director/PDMR Shareholding

RNS Number : 2436P

Mediclinic International PLC

15 November 2016

 

Mediclinic International PLC (the "Company")
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC

JSE Share Code: MEI
NSX Share Code: MEP

ISIN: GB00B8HX8Z88

15 November 2016

NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Daniël Petrus Meintjes
2.	Reason for the notification
a)	Position / status	Chief Executive Officer of the Company
b)	Initial notification / amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name		Mediclinic International plc
b)	LEI		N/A
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification Code	Ordinary Shares GB00B8HX8Z88
b)	Nature of the transaction	Acquisition
c)	Price(s) and volume(s)	Price(s) Volume(s) ZAR132.74 per share 3,485
d)	Aggregated information Aggregated volume Price	N/A
e)	Date of the transaction	14 November 2016
f)	Place of the transaction	Johannesburg Stock Exchange

Registered address: 1^st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom

Website: www.mediclinic.com

JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Ltd

For further information please contact:

Mediclinic International plc

James Arnold, Head of Investor Relations

[e-mail]

Capita Company Secretarial Services Limited

Victoria Dalby

[phone]

 

END

 

 

DSHBXBDBISBBGLU